ID   CET-IPF-FFCYSTFIB2-500
AC   CVCL_B5V9
DR   Wikidata; Q111733095
RX   PubMed=30488785;
WW   Provider; JP2MRI; -; https://www.jp2mri.org/cystic-fibrosis-male-7-cd34
CC   From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA.
CC   From: John Paul II Medical Research Institute; Coralville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (JP2MRI).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
RX   PubMed=30488785; DOI=10.2217/rme-2018-0041;
RA   Kamath A., Ternes S., McGowan S., Moy A.B.;
RT   "Virus-free and oncogene-free induced pluripotent stem cell
RT   reprogramming in cord blood and peripheral blood in patients with
RT   lung disease.";
RL   Regen. Med. 13:889-915(2018).
//